Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vir Biotechnology, Inc. (VIR)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 127,390,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. Co.'s existing pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus, influenza A virus, and human immunodeficiency virus. Co. has collaborate with Glaxo Wellcome UK Limited and GlaxoSmithKline Biologicals S.A. to focus on treating and preventing severe acute respiratory syndrome coronavirus 2 (the virus that causes COVID-19 illness). Co. is developing differentiated monoclonal antibodies, like sotrovimab and VIR-7832, as well as vaccines and small molecules.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 10,000
Total Buy Value $0 $0 $0 $246,341
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 4
Total Shares Sold 136,328 167,399 782,068 6,005,613
Total Sell Value $1,354,144 $1,671,921 $17,840,473 $153,953,368
Total People Sold 5 5 9 11
Total Sell Transactions 7 10 24 123
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 575
  Page 20 of 23  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Parrish Jay Chief Business Officer   •       –      –    2020-10-01 4 OE $1.49 $10,522 D/D 6,945 229,167     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-29 4 AS $38.00 $133,380 D/D (3,510) 23,700     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-29 4 OE $1.53 $5,370 D/D 3,510 27,210     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-24 4 OE $1.53 $5,661 D/D 3,700 23,700     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-22 4 AS $31.71 $120,638 D/D (3,805) 20,000     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-22 4 OE $1.53 $5,822 D/D 3,805 23,805     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-09-16 4 AS $31.88 $398,694 D/D (12,500) 29,777     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-09-16 4 OE $1.53 $28,001 D/D 12,500 42,277     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-08 4 AS $29.98 $114,098 D/D (3,805) 20,000     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-09-08 4 OE $1.53 $5,822 D/D 3,805 23,805     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-09-02 4 AS $32.88 $411,159 D/D (12,500) 29,777     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-09-02 4 OE $1.58 $19,688 D/D 12,500 42,277     -
   Parrish Jay Chief Business Officer   •       –      –    2020-09-01 4 AS $39.15 $271,796 D/D (6,943) 222,222     -
   Parrish Jay Chief Business Officer   •       –      –    2020-09-01 4 OE $1.58 $10,935 D/D 6,943 229,165     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-08-25 4 AS $42.92 $238,632 D/D (5,560) 20,000     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-08-25 4 OE $1.53 $39,107 D/D 25,560 25,560     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-08-19 4 AS $50.94 $636,855 D/D (12,500) 29,777     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-08-19 4 OE $0.86 $39,992 D/D 26,500 42,277     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-08-11 4 AS $51.08 $403,563 D/D (7,900) 0     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-08-11 4 OE $1.53 $12,087 D/D 7,900 7,900     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-08-05 4 AS $50.89 $636,222 D/D (12,500) 15,777     -
   Pang Phillip Chief Medical Officer   •       –      –    2020-08-05 4 OE $1.58 $19,688 D/D 12,500 28,277     -
   Parrish Jay Chief Business Officer   •       –      –    2020-08-03 4 AS $47.65 $529,404 D/D (11,110) 222,222     -
   Parrish Jay Chief Business Officer   •       –      –    2020-08-03 4 OE $1.49 $16,665 D/D 11,110 233,332     -
   Virgin Herbert EVP, Research & CSO   •       –      –    2020-07-28 4 AS $47.99 $379,090 D/D (7,900) 0     -
  575 Records found
  Previous  20  21  22  23   
  Page 20 of 23
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us